CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 520 enrolled
Drug / intervention
MoviPrep +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05054036
NCT05054036Phase 4Completed

Efficacy, Safety, and Tolerability of MoviPrep® Versus GoLYTELY® Bowel Preparation in Hospitalized Patients Undergoing Colonoscopy: a Randomized Control Trial

Yale University·interventional·Posted Sep 23, 2021·Updated Mar 11, 2026

In Brief

A Phase 4 clinical trial evaluating MoviPrep and Golytely for Bowel Preparation Before Colonoscopy. Completed, enrolled 520 participants across 2 sites.

Detailed Summary

Adequate bowel cleansing is a critical component in the care of hospitalized patients undergoing colonoscopy. However, inpatient status is a well-established risk factor for inadequate bowel preparation. However, few strategies have been rigorously shown to reduce the risk of inadequate bowel preparation. Moreover, inadequate bowel preparation is frequently related to the poor tolerability of high volumes of bowel preparation in the medically complex and comorbid hospitalized population. Low volume bowel preparations have been developed that have been shown to be noninferior compared to high volume bowel preparation with regards to adequacy of bowel preparation but with improved tolerability. However, the use of low volume bowel preparations for colonoscopies have largely been evaluated in the outpatient setting. In this study, we plan to compare rates of adequate bowel preparation and tolerability of a low volume bowel preparation, MoviPrep, compared to standard high volume bowel preparation, GoLYTELY, in hospitalized patients undergoing colonoscopy. This study promises to highlight low volume bowel preparation as a viable and better tolerated alternative to high volume bowel preparation in hospitalized patients which may ultimately decrease delays in inpatient endoscopy as well as hospital length of stay.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20222023202420252026
First PostedSep 23, 2021
Enrollment StartJan 12, 2022
Primary CompletionJul 1, 2024
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 4.8 years ago

Interventions

MoviPrepdrug

Split-dose MoviPrep bowel preparation

Golytelydrug

Split-dose GoLYTELY bowel preparation